Clinical Research Directory
Browse clinical research sites, groups, and studies.
Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?
Sponsor: Erasmus Medical Center
Summary
This study is a randomised, controlled, phase II trial to assess the efficacy of 2 hours normothermic machine perfusion (NMP) of extended criteria(EC)-DBD (donation after brain death) and DCD (donation after circulatory death) donor kidneys compared to standard care, which is hypothermic machine perfusion (HMP) only in the Netherlands.
Official title: Normothermic Machine Perfusion as Additional Value to Hypothermic Machine Perfusion for Kidney Transplant Outcomes. A Single-centre, Open-label, Randomised, Controlled Trial.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2021-05-01
Completion Date
2025-05
Last Updated
2024-05-07
Healthy Volunteers
No
Interventions
Normothermic machine perfusion
Additional 2h of normothermic machine perfusion of the donor kidney with a red cell based perfusate.
Locations (1)
Erasmus MC Transplant Institute
Rotterdam, Netherlands